Latin America Pharma Growth: Boehringer Ingelhe...

By HEOR Staff Writer

January 27, 2026

Latin America Pharma Growth is surging as a high-growth engine for Boehringer Ingelheim, with double-digit market expansions outpacing mature regions like Europe, according to
NICE Endorses Dupilumab for Eosinophilic COPD Treatment
NICE Endorses Talazoparib Enzalutamide for Prostate Cancer Treatment
Long-Term Benefits of Composite Treatment Targets in Type 2 Diabetes Management
EU Launches Joint Scientific Consultations to Enhance Health Technology Asses...
NHS Cost-Effectiveness Thresholds Boost Drug Approvals and Innovation
NICE Endorses Natalizumab RRMS Treatment Expansion for Refractory Cases
NICE Approves Seven Digital Cardiac Rehabilitation Technologies for Enhanced ...
Advancing EU Health Technology Assessment: Key Priorities in the HTACG Draft ...
Rethinking HEOR Market Access Integration: A Call for Early Engagement Before...
Emblaveo MDR Infections: Evaluating a New Solution for Multidrug-Resistant Gr...
NICE NHS Prioritization: A Strategic Shift to Address Healthcare Challenges
Challenging the Narrative: Pharmaceutical Innovation Funding and Its Complex ...